First Description of Marinoquinoline Derivatives’ Activity against <i>Toxoplasma gondii</i>

Toxoplasmosis is a globally prevalent zoonotic disease with significant clinical implications, including neurotoxoplasmosis, a leading cause of cerebral lesions in AIDS patients. The current pharmacological treatments for toxoplasmosis face clinical limitations, necessitating the urgent development...

詳細記述

書誌詳細

出版年:	Pharmaceutics
主要な著者:	Luiza Tamie Hirata Diethelm, Amanda Bruno da Silva Bellini Ramos, Giovanna Braga de Lorena, Bruna Inácio Trajano, Rafael Dias do Espírito Santo, Renata Priscila Barros de Menezes, Marcus Tullius Scotti, Fabio Antonio Colombo, Marcos José Marques, Carlos Roque Duarte Correia, Juliana Quero Reimão
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-02-01
主題:	toxoplasmosis marinoquinolines anti-<i>T. gondii</i> activity therapeutics in vitro evaluation in vivo efficacy
オンライン･アクセス:	https://www.mdpi.com/1999-4923/16/2/262